Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
E-PRA and E-PSM
E-PRA and E-PSM Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0455
E-PRA and E-PSM Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding E-PRA and E-PSM was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0455-LNP
E-PRA and E-PSM Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TARP 27-35 peptide
TARP 27-35 peptide Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0456
TARP 27-35 peptide Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TARP 27-35 peptide was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0456-LNP
TARP 27-35 peptide Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TARP 29-37-9V
TARP 29-37-9V Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0457
TARP 29-37-9V Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TARP 29-37-9V was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0457-LNP
TARP 29-37-9V Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEA
CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0458
CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0458-LNP
CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
hTERT((611-626)
hTERT((611-626) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0459
hTERT((611-626) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding hTERT((611-626) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0459-LNP
hTERT((611-626) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TERT
TERT Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0460
TERT Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TERT was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0460-LNP
TERT Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
hTERT(540 to 548)
hTERT(540 to 548) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0461
hTERT(540 to 548) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding hTERT(540 to 548) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0461-LNP
hTERT(540 to 548) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
MAGE-1
MAGE-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0462
MAGE-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding MAGE-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0462-LNP
MAGE-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
MART-1 (26-35, 27L)/gp100 (209-217, 210M)/tyrosina
MART-1 (26-35, 27L)/gp100 (209-217, 210M)/tyrosinase (368-376, 370D) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0463
MART-1 (26-35
In Vitro Transcribed mRNA template encoding MART-1 (26-35
CVAC-ORNA-0463-LNP
27L)/gp100 (209-217
27L)/gp100 (209-217
Alpha-N-acetylgalactosamine (Tn)
Alpha-N-acetylgalactosamine (Tn) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0464
Alpha-N-acetylgalactosamine (Tn) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Alpha-N-acetylgalactosamine (Tn) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0464-LNP
Alpha-N-acetylgalactosamine (Tn) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.246749s